0001179110-18-012091.txt : 20181009
0001179110-18-012091.hdr.sgml : 20181009
20181009142049
ACCESSION NUMBER: 0001179110-18-012091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181005
FILED AS OF DATE: 20181009
DATE AS OF CHANGE: 20181009
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leamon Christopher P
CENTRAL INDEX KEY: 0001509415
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35050
FILM NUMBER: 181113336
MAIL ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENDOCYTE INC
CENTRAL INDEX KEY: 0001235007
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
BUSINESS PHONE: 7654637175
MAIL ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
4
1
edgar.xml
FORM 4 -
X0306
4
2018-10-05
0
0001235007
ENDOCYTE INC
ECYT
0001509415
Leamon Christopher P
3000 KENT AVE, SUITE A1-100
WEST LAFAYETTE
IN
47906
0
1
0
0
Vice President of Research
Common Stock
2018-10-05
4
S
0
9028
15.5557
D
121353
D
Represents the sale of 9,028 shares in multiple transactions, ranging in price from $15.1300 to $15.9200, resulting in a weighted-average sale price per share of $15.5557. The 9,028 shares were sold to cover taxes, commissions and fees associated with the October 4, 2018 settlement of 20,000 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
/s/ Michael A. Sherman, Attorney-in-Fact for Christopher P. Leamon (power of attorney previously filed)
2018-10-09